Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F11 | P03951 | 19/20 | 0.81 |
| ▸ | KLKB1 | P03952 | 5/20 | 0.60 |
| ▸ | F9 | P00740 | 3/20 | 0.60 |
| ▸ | F12 | P00748 | 1/20 | 0.59 |
| ▸ | PLAT | P00750 | 1/20 | 0.59 |
| ▸ | PROC | P04070 | 1/20 | 0.59 |
| ▸ | F7 | P08709 | 1/20 | 0.59 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.59 |
| ▸ | CTRL | P40313 | 1/20 | 0.59 |
| ▸ | CTRB2 | Q6GPI1 | 1/20 | 0.59 |
| ▸ | CTRC | Q99895 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17448686 | 0.95 | F11 (0.78) | F11KLKB1F9F12PLAT | |
| SCHEMBL20879234 | 0.90 | F11 (0.65) | F11KLKB1F9F12PLAT | |
| SCHEMBL20879307 | 0.89 | F11 (1.00) | F11KLKB1F9F12PLAT | |
| SCHEMBL14700818 | 0.89 | F11 (1.00) | F11KLKB1F9F12PLAT | |
| SCHEMBL20879252 | 0.89 | F11 (0.80) | F11KLKB1F9F12PLAT | |
| SCHEMBL20879220 | 0.89 | F11 (1.00) | F11KLKB1F9F12PLAT | |
| SCHEMBL15782187 | 0.89 | F11 (1.00) | F11KLKB1F9F12PLAT | |
| SCHEMBL14700885 | 0.89 | F11 (1.00) | F11KLKB1F9F12PLAT | |
| SCHEMBL20879289 | 0.85 | F11 (0.77) | F11KLKB1F9F12PLAT | |
| SCHEMBL18083186 | 0.84 | F11 (0.78) | F11KLKB1F9F12PLAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013022814-A1 | CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |